James Paul Rickey is CFO & VP at ALPINE IMMUNE SCIENCES, INC. (ALPN). They have made 3 open-market trades across 2 companies since 2019, most recently 2026-08-07.
CIK 0001606243
2 open-market purchases totalling $549K since 2019, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BRVE | 520,927 | $9.7M |
| ALPN | 38,256 | $2.5M |
| Total | $12.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BRVE | BUY | 2026-08-07 | 2026-08-07 | $18.00 | $500K | -3.3% | -3.6% | — |
| ALPN | SELL · 10b5-1 | 2024-01-25 | 2024-01-29 | $22.93 | $4.4M | +10.4% | +35.7% | +151.5% |
| ALPN | SELL · 10b5-1 | 2023-12-19 | 2023-12-21 | $19.21 | $584K | -9.2% | -1.6% | +99.4% |
| ALPN | SELL · 10b5-1 | 2023-12-14 | 2023-12-18 | $19.08 | $2.0M | -0.2% | +6.4% | +85.7% |
| ALPN | SELL · 10b5-1 | 2023-12-04 | 2023-12-06 | $16.06 | $2.3M | +13.3% | +6.3% | +124.4% |
| ALPN | SELL · 10b5-1 | 2023-11-30 | 2023-12-01 | $16.00 | $11K | +23.3% | +24.6% | +131.0% |
| ALPN | SELL · 10b5-1 | 2023-11-06 | 2023-11-08 | $16.03 | $577K | +13.5% | +36.2% | +114.6% |
| ALPN | SELL | 2021-12-31 | 2022-01-04 | $13.92 | $474K | -20.7% | -44.6% | -28.4% |
| ALPN | BUY | 2019-05-30 | 2019-06-03 | $4.95 | $50K | -15.4% | -11.1% | -6.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.